Correlation Between Merck KGaA and Cannara Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merck KGaA and Cannara Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck KGaA and Cannara Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck KGaA ADR and Cannara Biotech, you can compare the effects of market volatilities on Merck KGaA and Cannara Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck KGaA with a short position of Cannara Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck KGaA and Cannara Biotech.

Diversification Opportunities for Merck KGaA and Cannara Biotech

-0.07
  Correlation Coefficient

Good diversification

The 3 months correlation between Merck and Cannara is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Merck KGaA ADR and Cannara Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannara Biotech and Merck KGaA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck KGaA ADR are associated (or correlated) with Cannara Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannara Biotech has no effect on the direction of Merck KGaA i.e., Merck KGaA and Cannara Biotech go up and down completely randomly.

Pair Corralation between Merck KGaA and Cannara Biotech

Assuming the 90 days horizon Merck KGaA is expected to generate 6.72 times less return on investment than Cannara Biotech. But when comparing it to its historical volatility, Merck KGaA ADR is 2.09 times less risky than Cannara Biotech. It trades about 0.14 of its potential returns per unit of risk. Cannara Biotech is currently generating about 0.47 of returns per unit of risk over similar time horizon. If you would invest  54.00  in Cannara Biotech on November 4, 2024 and sell it today you would earn a total of  21.00  from holding Cannara Biotech or generate 38.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Merck KGaA ADR  vs.  Cannara Biotech

 Performance 
       Timeline  
Merck KGaA ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck KGaA ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Cannara Biotech 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Cannara Biotech reported solid returns over the last few months and may actually be approaching a breakup point.

Merck KGaA and Cannara Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merck KGaA and Cannara Biotech

The main advantage of trading using opposite Merck KGaA and Cannara Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck KGaA position performs unexpectedly, Cannara Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannara Biotech will offset losses from the drop in Cannara Biotech's long position.
The idea behind Merck KGaA ADR and Cannara Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum